Trial · NCT04712669
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline of Pulmonary Vascular Resistance (PVR) at Week 24 | Rodatristat Ethyl 300 mg BID | 63.083 | Standard Error 18.529 | percent | |
| Percent Change From Baseline of Pulmonary Vascular Resistance (PVR) at Week 24 | Rodatristat Ethyl 600 mg BID | 64.219 | Standard Error 18.013 | percent | |
| Percent Change From Baseline of Pulmonary Vascular Resistance (PVR) at Week 24 | Placebo | 5.813 | Standard Error 18.052 | percent | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Rodatristat Ethyl 300 mg BID | -II | 0 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Rodatristat Ethyl 600 mg BID | -II | 0 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Placebo | -II | 0 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Rodatristat Ethyl 300 mg BID | -I | 2 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Rodatristat Ethyl 600 mg BID | -I | 3 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Placebo | -I | 3 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Rodatristat Ethyl 300 mg BID | No Change | 30 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Rodatristat Ethyl 600 mg BID | No Change | 30 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Placebo | No Change | 30 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Rodatristat Ethyl 300 mg BID | I | 4 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Rodatristat Ethyl 600 mg BID | I | 3 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Placebo | I | 3 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Rodatristat Ethyl 300 mg BID | II | 0 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Rodatristat Ethyl 600 mg BID | II | 0 | Participants | |
| Change From Baseline in World Health Organization (WHO) Functional Class (FC) | Placebo | II | 0 | Participants | |
| Change From Baseline in Six-minute Walk Distance (6MWD) | Rodatristat Ethyl 300 mg BID | -14.5 | Inter-Quartile Range -31.50 to 28.00 | six-minute walk distance (6MWD) (meters) | |
| Change From Baseline in Six-minute Walk Distance (6MWD) | Rodatristat Ethyl 600 mg BID | 0 | Inter-Quartile Range -27.50 to 20.00 | six-minute walk distance (6MWD) (meters) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04712669/results